Janicki Piotr K, Ruiz-Velasco Victor, Adhikary Sanjib
Anesthesiology and Perioperative Medicine, Penn State Milton S. Hershey Medical Center, Hershey, USA.
Cureus. 2019 May 2;11(5):e4587. doi: 10.7759/cureus.4587.
A 68-year-old female with a history of sporadic type and presumably secondary erythromelalgia with chronic intractable pain presented for foot surgery. The procedure was performed with combined general anesthesia and regional anesthesia consisting of the placement of a popliteal pain catheter for postoperative pain management. Subsequent whole-genome sequencing revealed that the patient was a homozygous carrier of the common missense mutation in the SCN9A gene coding for voltage-gated sodium channel (NaV1.7) - dbSNP rs6746030 (R1150W). The occurrence of this single nucleotide polymorphism (SNP) was previously suggested not to be associated with erythromelalgia but rather thought to be part of quantitative changes in the pain threshold in different cohorts of patients. The placement of the pain catheter, although controversial in patients with erythromelalgia, provided effective postoperative pain relief without any side effects.
一名68岁女性,有散发性类型病史,推测为继发性红斑性肢痛症伴慢性顽固性疼痛,前来接受足部手术。手术采用全身麻醉和区域麻醉相结合的方式,包括放置腘窝疼痛导管用于术后疼痛管理。随后的全基因组测序显示,该患者是编码电压门控钠通道(NaV1.7)的SCN9A基因常见错义突变的纯合携带者——dbSNP rs6746030(R1150W)。此前认为这种单核苷酸多态性(SNP)的出现与红斑性肢痛症无关,而是被认为是不同患者群体疼痛阈值定量变化的一部分。疼痛导管的放置,尽管在红斑性肢痛症患者中存在争议,但提供了有效的术后疼痛缓解且无任何副作用。